From: Immune gene expression profiling reveals heterogeneity in luminal breast tumors
 | Low-TIL, N (%) | High-ISG, N (%) | High-TIL, N (%) | HER2+basal, N (%) | |
---|---|---|---|---|---|
HKBC | A/A | 10 (29.4%) | 9 (32.2%) | 3 (21.4%) | 15 (46.9%) |
A/C | 17 (50.0%) | 15 (53.5%) | 8 (57.2%) | 13 (40.6%) | |
C/C | 7 (20.6%) | 4 (14.3%) | 3 (21.4%) | 4 (12.5%) | |
P value* | Ref | 0.89 | 0.92 | 0.35 | |
TCGA White | A/A | 111 (90.3%) | 117 (86.0%) | 60 (85.7%) | 158 (92.9%) |
A/C | 11 (8.9%) | 18 (13.3%) | 10 (14.3%) | 10 (5.9%) | |
C/C | 1 (0.8%) | 1 (0.7%) | 0 (0%) | 2 (1.2%) | |
P value* | Ref | 0.66 | 0.44 | 0.62 |